Earlier this month, a $289 million increase in funding for Alzheimer’s and other dementia research at the National Institutes of Health (NIH) was approved by Congress and signed into law by President Biden. Added to current NIH spending, the annual Alzheimer's and dementia research funding by the federal government will be more than $3.4 billion. Additionally, $25 million for BOLD Infrastructure for Alzheimer’s Act implementation at the Centers for Disease Control and Prevention (CDC) was also included in the Fiscal Year (FY) 2022 appropriations omnibus. 

We commend our bipartisan congressional champions for their continued commitment to ensuring a robust Alzheimer’s and dementia research budget at the NIH and critical investment in the Alzheimer’s public health response. Thank you to our advocates who continue to work tirelessly to build support for increased investment by meeting with legislators, calling their members' offices, writing letters to the editor and engaging lawmakers on social media.

Today, the over six million Americans living with Alzheimer’s and their caregivers have greater access than ever before to critical care and support services. With sustained investment for the federal government, we will continue to see breakthroughs in treatment, prevention and ultimately, a cure.

Alzheimer’s is a devastating disease impacting families and communities throughout the nation. Congressional action is needed to stay on the path to discovering scientific breakthroughs. We are grateful to Congress for their ongoing support, and now we must keep this momentum going into the FY23 appropriations season.

For FY23, we are asking Congress for a $226 million increase in Alzheimer’s and dementia research funding at the NIH and $30 million for BOLD implementation at the CDC. Join us in urging Congress to stand up for people living with Alzheimer’s and increase research funding. Take action today!